T2	ENHANCER 640 649	enhancers
T3	ENHANCER 771 784	two enhancers
T4	PROMOTER 875 883	promoter
T6	GENE 89 99	E-cadherin
N0	Reference T6 EntrezGene:12550	Cdh1
T7	GENE 390 394	Cdh1
N1	Reference T7 EntrezGene:12550	Cdh1
T8	GENE 396 406	E-cadherin
N2	Reference T8 EntrezGene:12550	Cdh1
T9	GENE 433 437	Cdh1
N3	Reference T9 EntrezGene:12550	Cdh1
T10	GENE 563 568	Grhl3
N4	Reference T10 EntrezGene:230824	rhl3
T11	GENE 573 582	Hnf4alpha
N5	Reference T11 EntrezGene:15378	Hnf4
T12	GENE 613 618	Grhl3
N6	Reference T12 EntrezGene:230824	rhl3
T13	GENE 623 632	Hnf4alpha
N7	Reference T13 EntrezGene:15378	Hnf4
T14	GENE 676 680	Cdh1
N8	Reference T14 EntrezGene:12550	Cdh1
T16	GENE 799 804	Grhl3
N10	Reference T16 EntrezGene:230824	rhl3
T17	GENE 809 818	Hnf4alpha
N11	Reference T17 EntrezGene:15378	Hnf4
T18	GENE 899 909	E-cadherin
N12	Reference T18 EntrezGene:12550	Cdh1
A2	REGION T2 INSUFFICIENT
T15	TISSUE 706 747	non-tumorigenic mouse mammary gland cells
T32	TISSUE 749 754	NMuMG
N20	Reference T32 BTO:0004183	NMuMg cell
N9	Reference T15 BTO:0004183	NMuMg cell
A3	REGION T3 INSUFFICIENT
A4	REGION T4 INSUFFICIENT
T5	TISSUE 1184 1195	tumor cells
A5	CANCER T5
T1	ENHANCER 473 529	two enhancers at +7.8 kb and at +11.5 kb within intron 2
A1	REGION T1 INSUFFICIENT
